Risk of mortality for small newborns in Brazil, 2011-2018: A national birth cohort study of 17.6 million records from routine register-based linked data
Background: Preterm birth (<37 weeks), low birth weight (LBW,<2500g), and small for gestational age (SGA,<10th centile of birth weight for gestational age and sex) are markers of newborn vulnerability with a high risk of mortality. We estimated the prevalence of phenotypes combining these t...
Guardado en:
Autores principales: | Enny S. Paixao, Ph.D, Hannah Blencowe, MD, Ph.D, Ila Rocha Falcao, Ph.D, Eric O. Ohuma, Ph.D, Aline dos Santos Rocha, Flávia Jôse Oliveira Alves, Maria da Conceição N. Costa, MD, Ph.D, Lorena Suárez-Idueta, Naiá Ortelan, Ph.D, Liam Smeeth, MD, Ph.D, Laura C. Rodrigues, MD, Ph.D, Joy E Lawn, MB BS, Ph.D, Marcia Furquim de Almeida, MD, Ph.D, Maria Yury Ichihara, MD, PhD, Rita de Cássia Ribeiro Silva, Ph.D, Maria Gloria Teixeira, MD, Ph.D, Mauricio L. Barreto, MD, Ph.D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ca6c8093a804d25b9f1814ea0a05461 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021) -
Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million People
por: Naoki Tanimine, MD, PhD, et al.
Publicado: (2021) -
IL-17A–Mediated Immune-Inflammatory Periarticular Mass and Osteolysis From Impingement in Ceramic-On-Ceramic Total Hip Arthroplasty
por: Tsunehito Ishida, MD, PhD, et al.
Publicado: (2021) -
Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
por: Christina Routsi, MD, PhD, et al.
Publicado: (2021) -
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
por: Kei Kunimasa, MD, PhD, et al.
Publicado: (2021)